Collegium Pharmaceutical, Inc.
COLL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $69 | $48 | -$25 | $72 |
| Dep. & Amort. | $169 | $149 | $139 | $69 |
| Deferred Tax | -$27 | -$2 | -$8 | -$78 |
| Stock-Based Comp. | $32 | $27 | $23 | $24 |
| Change in WC | -$55 | $22 | -$13 | $13 |
| Other Non-Cash | $16 | $31 | $9 | $3 |
| Operating Cash Flow | $205 | $275 | $124 | $104 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$2 | -$2 |
| Net Acquisitions | -$268 | $0 | -$572 | $0 |
| Inv. Purchases | -$111 | -$92 | $0 | $0 |
| Inv. Sales/Matur. | $93 | $22 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$288 | -$71 | -$574 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8 | -$66 | $443 | -$50 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$60 | -$75 | -$14 | -$48 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8 | $1 | $8 | $9 |
| Financing Cash Flow | -$61 | -$140 | $437 | -$89 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$143 | $64 | -$13 | $12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $240 | $176 | $189 | $177 |
| End Cash | $97 | $240 | $176 | $189 |
| Free Cash Flow | $203 | $274 | $123 | $102 |